CPI Genocide wants to investigate the role of CFM and health plans in spreading “early treatment”

Pedro Zambarda de Araujo

President Jair Bolsonaro showing off hydroxychloroquine packaging Image: Reproduction

from Julia Chapp and Renato Machado in Folha de S. Paulo.

In addition to focusing on the Ministry of Health’s actions, the Covid do Senado CPI should expand the scope of the investigation to include other actors who have played a role in combating the novel coronavirus pandemic.

Read – Covid CPI to summon important scientists and doctors of the government, such as Nicolelis and Átila Iamarino

The committee will hold its first meeting on Tuesday (27), during which the chairperson, deputy chairperson and rapporteur will be chosen. Members can also start discussing the business plan.

Read more – MDB may turn Covid CPI into lockdown against Bolsonaro

Senator Humberto Costa (PT-PE) said he intends to present requirements to hear CFM (Federal Board of Medicine) members and health plans on the committee. The aim is to investigate the role of these organs in the prevalence of so-called “early treatment”.

In the senator’s view, the Senate encouraged the use of the drugs without proving their effectiveness from the moment he allowed the doctor to make his own decision.

The CFM unofficially presented one of the scientific bases for President Jair Bolsonaro (without a party) to further publicize and defend the administration of hydroxychloroquine for the treatment of Covid-19.

The board issued an opinion last year leaving doctors, in agreement with patients, to decide to use the drug in an “off-label” manner, outside of what is described in the package leaflet. Even Bolsonaro cited the release.

Doctors and scientific and medical bodies began to condemn the position of the Council of Foreign Ministers, for not reprimanding a position that conflicts with scientific knowledge.

See also  The "urban" fox from London hides leftovers even on the hood of a car; Watch the video | Globo Reporter

“The Brazilian Society for Infectious Diseases does not recommend early treatment of Covid-19 with any medicine because randomized clinical studies with control groups in place to date have not shown any benefit, plus some of these medicines can cause side effects,” the entity said in a January 14 post. / January on social media.

“I will submit a request for a meeting of the Federal Board of Medicine, which has had a very detrimental role in this process,” said the senator to Fulha.


You May Also Like

About the Author: Camelia Kirk

"Friendly zombie guru. Avid pop culture scholar. Freelance travel geek. Wannabe troublemaker. Coffee specialist."

Leave a Reply

Your email address will not be published. Required fields are marked *